Abstract
Our laboratory recently reported that interferon (IF) could augment human antibody-dependent cellular cytotoxicity (ADCC) and cytotoxicity by natural killer (NK) cells. Although there is general agreement that IF can boost the activity of human NK cells, two laboratories have reported a failure to boost ADCC. We have therefore examined in more detail the effects of IF on human ADCC. We have found, by several lines of evidence, that IF can indeed appreciably augment the activity of K cells, the subpopulation of lymphocytes that mediate ADCC: (1) human leucocyte IF, purified to homogeneity, boosted ADCC: (2) IF augmented ADCC against target cells that were completely resistant to NK activity; and (3) the ADCC activity of leukaemic cells from a patient with chronic lymphocytic leukaemia (CLL) which lacked any detectable NK activity was boosted by IF. These results are consistent with the hypothesis that human NK and K cells are the same subpopulation of lymphocytes and that the mechanisms regulating their activity are similar. However, the absence of NK activity in the CLL patient strongly supports the idea that not all FcR-positive cells are NK and that ADCC effectors devoid of NK may exist. However, further evidence is required ...Continue Reading
References
Aug 15, 1975·International Journal of Cancer. Journal International Du Cancer·R B HerbermanD H Lavrin
Jul 1, 1977·Journal of the National Cancer Institute·J R OrtaldoR B Herberman
Jan 18, 1979·Nature·R R HerbermanG D Bonnard
Jan 1, 1979·Cellular Immunology·I HeronK Berg
Feb 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M RubinsteinS Pestka
Aug 1, 1979·International Journal of Cancer. Journal International Du Cancer·H D KayG D Bonnard
Jan 1, 1978·Advances in Cancer Research·R B Herberman, H T Holden
May 1, 1978·The Journal of Experimental Medicine·G TrinchieriB B Knowles
Jun 15, 1977·International Journal of Cancer. Journal International Du Cancer·D Akira, M Takasugi
Citations
Jul 1, 1982·Journal of Clinical Immunology·D M StrongR B Herberman
Sep 1, 1986·Journal of Clinical Immunology·M P NairS A Schwartz
May 1, 1985·Journal of Reproductive Immunology·M P NairA E Beer
May 1, 1992·Antiviral Research·M C LaiN Swaminathan
Apr 1, 1990·The Journal of Experimental Medicine·M J SmythH A Young
Jan 1, 1981·Journal of Interferon Research·H BlomgrenJ Wasserman
Aug 1, 1986·Journal of Interferon Research·B S EdwardsE C Borden
May 1, 1981·Biological Reviews of the Cambridge Philosophical Society·C J Sanderson
Aug 15, 1989·Experientia·S ShiozawaT Fujita
Feb 15, 1983·Archives of Biochemistry and Biophysics·S Pestka
Nov 1, 1986·The American Journal of Medicine·M S Roth, K A Foon
Jun 1, 2002·Seminars in Oncology·Eva Kimby
Aug 1, 1985·Cellular Immunology·M P NairM Menon
Nov 1, 1984·Scandinavian Journal of Immunology·A R AlsheikhlyP Perlmann
Jan 1, 1985·Acta Radiologica. Oncology·P FlodgrenH O Sjögren
Mar 15, 1983·International Journal of Cancer. Journal International Du Cancer·J R OrtaldoR B Herberman
Sep 30, 1982·Biochimica Et Biophysica Acta·M Rubinstein
Feb 1, 1982·Cellular Immunology·R B HerbermanS Pestka